Atopic Eczema — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Withhold abrocitinib and arrange urgent antiviral and specialist assessment
JAK inhibition increases herpes-zoster risk. Multidermatomal disease may disseminate, so withhold treatment, assess urgently and start appropriate systemic antiviral therapy while evaluating immune status and organ involvement. Future vaccination and JAK-inhibitor risk–benefit can be reviewed after recovery; live vaccine is not used during active infection.
Reference: https://bnf.nice.org.uk/drugs/abrocitinib/